J CLIN INVEST 润色咨询

JOURNAL OF CLINICAL INVESTIGATION

出版年份:1924 年文章数:8077 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2024-10-19 GISL 来自重庆

    救命,20天了还在 Under consideration by Editorial Board

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2013-02-16 ms7446073747655445

    近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。
    做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投,

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2022-08-09 ms3000000449226234

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2025-08-20 ms3000000738875984 来自上海

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:难投

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2023-10-04 ms1000000589600011 来自瑞典

    审稿速度:2.0
    偏重的研究方向:免疫;肿瘤
    经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2025-06-27 ms5000000738743687 来自四川省

    偏重的研究方向:免疫;炎症;药理
    经验分享:6.10投稿,目前在编辑手里

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2025-04-03 shawnfang 来自广东省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:神经科学
    经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2025-03-18 ms1000000226329121 来自北京

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:细胞生物学
    经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2024-07-02 ms1000002046808533 来自广东省

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:一篇正在under consideration by editorial board

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2231650, encodeId=88882231650e2, content=救命,20天了还在 Under consideration by Editorial Board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=GISL, createdTime=Sat Oct 19 00:23:40 CST 2024, time=2024-10-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=823997, encodeId=6b8a82399ec8, content=近期中了一篇,是本实验第一次中。第一次审稿3周反馈,一个审稿人和开始在nature某子刊的审稿人是一个人,提了一些意见,但是喜欢我的文章;第二个提了一大堆意见,比较刻薄,第三个什么都不懂,问了一堆很傻很天真的问题。 <br> 做了2个月实验,用实验回答了全部56个问题的55个,只有第二评委一个问题是错的,没有做他要求的实验,而是解释了一下。一个月反馈回来,第一个评委接收,第二个对唯一的问题大作文章,第三个评委没出现,估计编辑没给他看,水平太差了。再补了一个月实验,很小心的反映出他问题本身的问题,复投, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567b5413997, createdName=ms7446073747655445, createdTime=Sat Feb 16 23:28:00 CST 2013, time=2013-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237579, encodeId=38a9123e579b4, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:大约4周收到初审意见,给了12个月补实验,再投回去的时候,还是送给之前的几个reviewer,大约3周回来意见,两个reviewer同意接收,另一个reviewer还有最后一个concern,编辑给了2个月时间回答,补了一个小实验,投回去,两天后接收,不确定最后有没有再给那个reviewer看。总的说来还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44ad8149203, createdName=ms3000000449226234, createdTime=Tue Aug 09 14:53:33 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278030, encodeId=a7c922e8030a9, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2478388689, createdName=ms3000000738875984, createdTime=Wed Aug 20 16:28:47 CST 2025, time=2025-08-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2160829, encodeId=3b9b2160829dc, content=审稿速度:2.0<br>偏重的研究方向:免疫;肿瘤<br>经验分享:回报本版,提供两篇文章的时间线。总的来说感觉编辑很有效率,各种沟通都很顺畅。 第一篇已经发表 20220418 提交 20220421 editorial review 20220425 external peer review 20220509 status modified 20220516 major revision。两个审稿人 20221207 修回稿提交 几次status modified之后在12月30号接收。 第二篇在修回 20230829 提交,当天under consideration 20230831 外审 20230906 status modified 20230908 status modified 20230912 status modified 20230914 status modified 20231001 status modified 20231003 大修,三个评审。 这一篇中间状态变了好多次,感觉可能是额外邀请了评审人。 目前在补实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c18135642, createdName=ms1000000589600011, createdTime=Wed Oct 04 04:58:18 CST 2023, time=2023-10-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2271044, encodeId=87a222e104442, content=偏重的研究方向:免疫;炎症;药理<br>经验分享:6.10投稿,目前在编辑手里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Fri Jun 27 10:13:18 CST 2025, time=2025-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2258960, encodeId=32ce225896065, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:神经科学<br>经验分享:投稿第一天,associate editor让我修改格式,第二天,转为under consideration by editoral board, 一个星期后拒稿。理由:稿件量大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo7ZPje2ZG8XdFTrM3dRGvtvzNHAB2PlicA2wv66YdDtw55hxsULCZLzicYSaNE0tRK59salhNA0xRw/132, createdBy=e5e52073583, createdName=shawnfang, createdTime=Thu Apr 03 14:34:49 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2256595, encodeId=21a02256595fa, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:细胞生物学<br>经验分享:JCI好难,5天拒稿,没有送审。理由是他们每年接收超4000的稿件。标准拒稿信,啥意见也没给, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cb5558800, createdName=ms1000000226329121, createdTime=Tue Mar 18 16:17:42 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2212785, encodeId=77482212e85fa, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一篇正在under consideration by editorial board, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52cc8288395, createdName=ms1000002046808533, createdTime=Tue Jul 02 14:28:51 CST 2024, time=2024-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207211, encodeId=a715220e211ef, content=请问大家 Under consideration by Editorial Board大概多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=ms1000000131596023, createdTime=Wed May 29 09:43:58 CST 2024, time=2024-05-29, status=1, ipAttribution=山东省)]
    2024-05-29 ms1000000131596023 来自山东省

    请问大家 Under consideration by Editorial Board大概多长时间?

    2

    展开2条回复
共207条页码: 1/21页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分